These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15222582)

  • 1. Dysport.
    Markey AC
    Dermatol Clin; 2004 Apr; 22(2):213-9. PubMed ID: 15222582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AbobotulinumtoxinA: A 25-Year History.
    Monheit GD; Pickett A
    Aesthet Surg J; 2017 May; 37(suppl_1):S4-S11. PubMed ID: 28388718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Different botulinum toxins and their specifications].
    Beylot C
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S77-85. PubMed ID: 19576490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of axillary hyperhidrosis with botulinum-A toxin.
    Salmanpoor R; Rahmanian MJ
    Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing two botulinum toxin type A formulations using manufacturers' product summaries.
    Wenzel R; Jones D; Borrego JA
    J Clin Pharm Ther; 2007 Aug; 32(4):387-402. PubMed ID: 17635341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of botulinum toxin type A and its clinical applications in migraine headache.
    Silberstein SD
    Expert Opin Pharmacother; 2001 Oct; 2(10):1649-54. PubMed ID: 11825307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in the treatment of axillary hyperhidrosis.
    Galadari I; Alkaabi J
    Skinmed; 2003; 2(4):209-11. PubMed ID: 14673273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of wrinkles with Botox.
    Klein AW
    Curr Probl Dermatol; 2002; 30():188-217. PubMed ID: 12471713
    [No Abstract]   [Full Text] [Related]  

  • 15. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
    Mantell AM
    Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M
    J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of botulinum toxins A and B in the treatment of facial rhytides.
    Sadick NS; Matarasso SL
    Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallic taste: an unusual reaction to botulinum toxin A.
    Murray C; Solish N
    Dermatol Surg; 2003 May; 29(5):562-3. PubMed ID: 12752530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.